Australia has the highest rate of skin cancer in the world — and melanoma is both the most dangerous form and a disease in which Australian researchers have made world-leading advances. Two in three Australians will be diagnosed with some form of skin cancer by age 70. Melanoma kills approximately 1,800 Australians every year. Grant funding supports research into treatment and prevention, sun safety education, patient support, and programmes targeting the outdoor workers and communities most at risk.
Scale
Why Australia?
Melanoma biology
Melanoma is more complex than it appears:
- Superficial spreading melanoma (most common)
- Nodular melanoma (most dangerous, fast-growing)
- Acral lentiginous (feet, hands, under nails — often in non-white populations)
- Uveal melanoma (eye)
- Mucosal melanoma (rare, aggressive)
Stage at diagnosis dramatically affects survival — from >95% at Stage I to approximately 25% at Stage IV (though immunotherapy has transformed this).
NHMRC
Research grants for melanoma biology, immunotherapy, and translational research — Australian researchers are global leaders in melanoma immunotherapy.
Cancer Australia
Priority-driven grants for melanoma and skin cancer.
MRFF
Translational research, clinical trials, and precision oncology for melanoma.
TGA
Regulatory support for new melanoma therapies — Australia has been an early approver of immunotherapy and targeted therapy.
SunSmart programmes (state health departments)
Primary prevention: sun safety education and infrastructure — funded through state health departments, Cancer Councils, and workplaces.
Melanoma Institute Australia (MIA)
Australia's largest melanoma research organisation:
- Research grants and fellowship funding
- Clinical trials coordination
- Patient support and advocacy
- International research collaborations
- Founded by Professor John Thompson — global leader in melanoma surgical research
Cancer Council (state)
Skin Cancer Foundation (Australia)
Prevention-focused education and awareness.
Melanoma Patients Australia (MPA)
Patient advocacy and peer support.
The Chris O'Brien Lifehouse Foundation
Melanoma treatment and supportive care at Lifehouse Cancer Centre (Sydney).
Research
Prevention
Early detection
Patient support
Outdoor workers
Construction workers, farmers, and outdoor labourers have very high skin cancer risk:
- Workplace sun safety policy development
- Protective clothing and sunscreen programmes
- Regular skin check access
- Industry-specific awareness
Indigenous and CALD skin cancer
Often overlooked — while Anglo-Celtic Australians have highest rates, all Australians need sun protection:
- Acral lentiginous melanoma more common in darker-skinned populations
- Culturally adapted sun safety education
- Access to early detection for all communities
Australian researchers have made globally significant contributions to melanoma treatment:
- Development of immunotherapy protocols now used worldwide
- Targeted therapy for BRAF-mutant melanoma
- Sentinel lymph node biopsy technique
- Adjuvant therapy after surgery (preventing recurrence)
This research legacy is a compelling argument for continued investment — Australian philanthropic funding has contributed to treatments now used globally.
Prevention ROI
Skin cancer prevention has excellent return on investment — sunscreen, shade, and education are cheap; treating advanced melanoma is expensive. Show prevention cost-effectiveness.
Immunotherapy revolution
The transformation of advanced melanoma from a disease with near-zero 5-year survival to 40-50%+ survival with immunotherapy is one of oncology's greatest success stories — and much of this happened in Australia. Applications aligned with building on this research legacy are compelling.
Outdoor workers
This group is often underserved — high-risk, difficult to reach, may not access health services. Workplace-based prevention programmes are a high-impact, underserved area.
Early detection technology
AI and telehealth are transforming skin cancer early detection — particularly for rural Australians. Applications bridging technology and community access are well-positioned.
Tahua's grants management platform supports cancer funders and melanoma research organisations — with clinical trial tracking, prevention programme management, outcome measurement, and the reporting tools that help skin cancer funders demonstrate their investment in Australia's most common and most researched cancer.